Speciality： She specializes in the chemotherapy of hematological malignancies for children

Clinical Interests：Leukemia, Lymphoma, Aplastic anemia, Thrombocytopenia, Langerhans cell histiocytosis

Education：She was conferred the Medical Doctor degree in Southern Medical University of China. She has been working at Division of Pediatric Hematology of Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences since 2012.

Professional Membership：She is a member of Youth Committee of Pediatric Oncology in Anticancer Association of Guangdong Province in China.

Publications

(1)Zhang JinFang, et al. HnRNP K contributes to drug resistance in acute myeloid leukemia through the regulation of autophagy. Experimental Hematology，2016,44(9)：850~856. (Corresponding author)

(2)Zhang JinFang, et al. EphB4-VAV1 signaling pathway is associated with imatinib resistance in chronic myeloid leukemia cells. Blood Cells Molecules and Diseases，2016, 59：58~62. (First author)

(3)Zhang JinFang, et al. Analysis of altered proteins related to blast crisis in chronic myeloid leukemia by proteomic study. International journal of laboratory hematology, 2012; 34(3): 267-273. (First author)